Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (6): 489-495.doi: 10.35541/cjd.20230004

• Guidelines and Consensus • Previous Articles     Next Articles

Expert consensus on treat-to-target in chronic spontaneous urticaria (2023)

Chinese Society of Dermatology, China Dermatologist Association   

  1. Chinese Society of Dermatology, China Dermatologist Association
  • Received:2023-01-03 Revised:2023-03-10 Online:2023-06-15 Published:2023-06-05
  • Contact: Xiao Ting; Zhao Zuotao; Gao Xinghua;;

Abstract: 【Abstract】 Chronic spontaneous urticaria (CSU) is the most common phenotype of chronic urticaria. Liscenced-dosed, up-dosed, or combined second-generation H1-antihistamines are choices for the treatment of CSU. However, approximately 50% of patients with CSU are resistant to antihistamine therapies. The treat-to-target approach has been proven to improve the quality of chronic disease management, but has not been proposed in CSU in China so far. Based on the latest guidelines, consensus, clinical trials and real-world studies in China and other countries, and combined with experts′ clinical experience, 31 Chinese experts in the field of urticaria diagnosis and treatment and related fields developed this consensus on treat-to-target in CSU, aiming to provide detailed guidance to clinicians.

Key words: Urticaria, Chronic spontaneous urticaria, Treat-to-target, Consensus